StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > .43 after reverse split .. lol

<< Previous

Bullboard Posts

Next >>

Comment by bigguy23on Jul 31, 2021 11:09am

120 Views

Post# 33636965

RE:RE:.43 after reverse split .. lol

oh yes, all investors are stupid to be here, it somehow begs the question, " Why are you here, still posting, without owning shares". I bet you won't be here after Sept, 2021. I know and many others know you will be sitting in some corner sobbing. We especially some of us don't take your advice, so you are welcome to keep your advice to yourself

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks